CA2142900A1 - Penile implant with triglyceride fill - Google Patents
Penile implant with triglyceride fillInfo
- Publication number
- CA2142900A1 CA2142900A1 CA002142900A CA2142900A CA2142900A1 CA 2142900 A1 CA2142900 A1 CA 2142900A1 CA 002142900 A CA002142900 A CA 002142900A CA 2142900 A CA2142900 A CA 2142900A CA 2142900 A1 CA2142900 A1 CA 2142900A1
- Authority
- CA
- Canada
- Prior art keywords
- penile implant
- bladder
- implant
- reservoir
- hydraulic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/26—Penis implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0095—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof radioactive
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Prostheses (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Abstract
A penile prosthesis (12) or implant utilizes expandable cylinders or bladders (14) implanted in the penis along with a fluid transfer system including a pump (18), hydraulic reservoir (24), and interconnecting fuid lines, connectors, etc. The prosthesis includes a biocompatible triglyceride with radiopaque dye as the hydraulic fluid (20) utilizes radiolucent materials to form the bladder (14) to enhance leak detection, and textures the exterior surface of the reservoir and bladders in order to decrease the likelihood of failure through fold flaw or capsular contracture.
Description
-- 214~900 W094/04095 ^ PCT/US9~/078 PENILE IMPLANT WITH TRIGLYCERIDE FILL
ross-Reference to Related A~plications -~
Thiæ application is a continuation-in-part of U.S.
Application Serial No. 07/932,603 filed August 20, 1992:
and is related to U.S. Application Serial No. 07/952,687 5 filed September 29, 1992 Back~round and Summarv of the Invention Implantable penile prostheses are well known in the art and generally include a pair of bladder-like penile implants for implantation into the two corpora 10 cavernosa, a fluid transfer system including a reservoir for containing 50 c.c. of a hydraulic liquid fill, and a ~-pump with a set of valves in fluid lines interconnecting the implants with the reservoir. The fluid transfer ' system is generally constructed of elastomeric compo-15 nents, including tubing and connectors, and silicone is a I ~ ~ typical material used for their construction. Because of ¦ its size, the reservoir is generally implanted in the¦ abdomen while the pump is generally bulb-shaped and is typically implanted within the male scrotum. Erection is 20 typically achieved by pumping the bulb-like pump to ; ,, ... .. . . .
W094/~40~9 0o PCT/US93/078 transfer fluid from the reservoir into the bladder-like s penile implants. Examples of these devices are shown in the following U.S. Patents: Patent Na. 3,954,102, Patent No. 4,360,010; Patent No. 4,424,807; ~atent No.
5 4,558,693; Patent No. 4,881,530; and Patent No. -~
5,101,813. ; `
The hydraulic fluid generally used in the prior art includes silicone oil, saline, water, and other kinds of non-spec~fic "biocomp~tible filler". These materials 10 are generally chosen because of their presumed biocompat-ability and/or lubricity. In U.S. Patent No. 3,954,102, a biocompatible fill is suggested which may be doctored with a biocompatible radiopaque dye in order to facili- `
tate the tracing of any leaks from the system to thereby 15 localize and minimize the required surgical intrusion to cor~ect the leak. The tracing of leaks is an important conslderation for prior art penile implants because of their regular ~se and resulting significant incidence of failure.
In performance of the intended use of penile implants, there is a regular cycling of the hydraulic fill from the reservoir to the bladders and then back again. Because of this cycling of fluid, there is a focus on the abrasive effect that the fluid has on the 25 bladders, as well as the pump and its valves, and the tubes and connectors, over time. This is because of the risk of deterioration, leakage, and even rupture of one or more of the system components. With the fill material suggested and used in the prior art, problems arising 30 from this abrasive action, including most often pump j failure, fluid line and connector leakage, and fold flaw failure have occurred with some degree of regularity.
I Still another type of failure involves the formation of a i scar capsule around the reservoir, and contraction of 35 this capsule to restrict the reservoir and interfere with - the deflation of the bladders. This leaves the patient ..'..
, 21429~0 with an erection which cannot be relieved. This "capsu-lar contracture" is similar to that which is experienced s with breast implants in women where a breast implant is , surrounded with a scar capsule which aontracts into a 5 painfully hard, clrcular mass which renders the breast hard and unnaturally shaped.
In the prior art, reservoirs are generally left , fllled for up to six weeks so that if a scar capsule forms, it will form to a size permitting the reservoir to ~
10 be fully refilled after the implant has been operated. ;
Unfortunately, the scar capsule can still contract and tighten over time such that this prior art protocol is not entirely successful.
With prior art devices, leaks are detected and -`
15 localized by using a frontal x-ray wherein the x-ray ~;
intensity and exposure time used is similar to that for a ~-chest x-ray as the x-rays are required to traverse a substantial amount of body tissue. This x-ray intensity i explained the need, mentioned above, for a biocompatible 20 radiopaque dye to be utilized as other structure, even silicone, used in the implant becomes transparent in these radiographs. However, for those implants utilizing a saline filler material, even a radiopaque dye is not successful in all cases in finding a leak as the human 25 body can metabolize saline relatively quickly, perhaps --~
overnight. Thus, in the prior art, detection and loca-tion of leaks utilizing x-ray was not completely success- ~`
ful. This was unfortunate as the ability to locate a leak is very important in correcting it with surgery.
30 Upon detection of the leak, the failed component could be identified as well as the site necessary for surgical ;~ -invasion. Thus, saline filler with radiopaque dye did not completely solve the problem of locating leaks.
`-~ Still another problem in the prior art with the 35 use of sal~ne as a hydraulic filler is the tendency for the penis to feel abnormal and perhaps like an inflated -`
;:;
, ~
W094/0409~ i PCT/US93~078~
ross-Reference to Related A~plications -~
Thiæ application is a continuation-in-part of U.S.
Application Serial No. 07/932,603 filed August 20, 1992:
and is related to U.S. Application Serial No. 07/952,687 5 filed September 29, 1992 Back~round and Summarv of the Invention Implantable penile prostheses are well known in the art and generally include a pair of bladder-like penile implants for implantation into the two corpora 10 cavernosa, a fluid transfer system including a reservoir for containing 50 c.c. of a hydraulic liquid fill, and a ~-pump with a set of valves in fluid lines interconnecting the implants with the reservoir. The fluid transfer ' system is generally constructed of elastomeric compo-15 nents, including tubing and connectors, and silicone is a I ~ ~ typical material used for their construction. Because of ¦ its size, the reservoir is generally implanted in the¦ abdomen while the pump is generally bulb-shaped and is typically implanted within the male scrotum. Erection is 20 typically achieved by pumping the bulb-like pump to ; ,, ... .. . . .
W094/~40~9 0o PCT/US93/078 transfer fluid from the reservoir into the bladder-like s penile implants. Examples of these devices are shown in the following U.S. Patents: Patent Na. 3,954,102, Patent No. 4,360,010; Patent No. 4,424,807; ~atent No.
5 4,558,693; Patent No. 4,881,530; and Patent No. -~
5,101,813. ; `
The hydraulic fluid generally used in the prior art includes silicone oil, saline, water, and other kinds of non-spec~fic "biocomp~tible filler". These materials 10 are generally chosen because of their presumed biocompat-ability and/or lubricity. In U.S. Patent No. 3,954,102, a biocompatible fill is suggested which may be doctored with a biocompatible radiopaque dye in order to facili- `
tate the tracing of any leaks from the system to thereby 15 localize and minimize the required surgical intrusion to cor~ect the leak. The tracing of leaks is an important conslderation for prior art penile implants because of their regular ~se and resulting significant incidence of failure.
In performance of the intended use of penile implants, there is a regular cycling of the hydraulic fill from the reservoir to the bladders and then back again. Because of this cycling of fluid, there is a focus on the abrasive effect that the fluid has on the 25 bladders, as well as the pump and its valves, and the tubes and connectors, over time. This is because of the risk of deterioration, leakage, and even rupture of one or more of the system components. With the fill material suggested and used in the prior art, problems arising 30 from this abrasive action, including most often pump j failure, fluid line and connector leakage, and fold flaw failure have occurred with some degree of regularity.
I Still another type of failure involves the formation of a i scar capsule around the reservoir, and contraction of 35 this capsule to restrict the reservoir and interfere with - the deflation of the bladders. This leaves the patient ..'..
, 21429~0 with an erection which cannot be relieved. This "capsu-lar contracture" is similar to that which is experienced s with breast implants in women where a breast implant is , surrounded with a scar capsule which aontracts into a 5 painfully hard, clrcular mass which renders the breast hard and unnaturally shaped.
In the prior art, reservoirs are generally left , fllled for up to six weeks so that if a scar capsule forms, it will form to a size permitting the reservoir to ~
10 be fully refilled after the implant has been operated. ;
Unfortunately, the scar capsule can still contract and tighten over time such that this prior art protocol is not entirely successful.
With prior art devices, leaks are detected and -`
15 localized by using a frontal x-ray wherein the x-ray ~;
intensity and exposure time used is similar to that for a ~-chest x-ray as the x-rays are required to traverse a substantial amount of body tissue. This x-ray intensity i explained the need, mentioned above, for a biocompatible 20 radiopaque dye to be utilized as other structure, even silicone, used in the implant becomes transparent in these radiographs. However, for those implants utilizing a saline filler material, even a radiopaque dye is not successful in all cases in finding a leak as the human 25 body can metabolize saline relatively quickly, perhaps --~
overnight. Thus, in the prior art, detection and loca-tion of leaks utilizing x-ray was not completely success- ~`
ful. This was unfortunate as the ability to locate a leak is very important in correcting it with surgery.
30 Upon detection of the leak, the failed component could be identified as well as the site necessary for surgical ;~ -invasion. Thus, saline filler with radiopaque dye did not completely solve the problem of locating leaks.
`-~ Still another problem in the prior art with the 35 use of sal~ne as a hydraulic filler is the tendency for the penis to feel abnormal and perhaps like an inflated -`
;:;
, ~
W094/0409~ i PCT/US93~078~
2~4~9~ 4 ~
balloon, even when flaccid. Obviously, the cosmetic and aesthetic value of the penile implant would be impaired to the extent that it does not achieve a normal and natu-ral "feel". This "water balloon effect" is more pro-5 nounced in a partially deflated pznis which ~s the pre-dominant condition for the patient's everyday life. This effect is exacerbated by the fact that penile implants are generally not totally deflatable.
The inventors herein are aware of the various 10 texturing and profiling of breast implants which have been developed in the prior art in order to r~nder them more biocompatible and diminish the likelihood of the formation of capsular contracture. Some examples of these are to be found in the following U.S. patents:
15 4,531,244; 4,648,880; 4,899,744; 4,955,907; 4,~55,909;
4,~60,425, 4,963,150; 5,007,929; 5,011,494; 5,022,942;
and 5,092,348, the disclosures of which are incorporated herein by reference. Generally, to the inventors' knowl-edge, these techniques have been used with success in 20 breast implants but their teachings have not been uti-lized with respect to other implants, includ~ng penile implants. Of course, as known in the art, mammographies are performed at significantly reduced x-ray intensities and exposures, levels heretofore not useful with respect 25 to penile implants.
The inventors herein are also aware of U.S. Patent No. 4,995,882, incorporated herein by reference, and rights to which are owned by the assignee of the present invention, which discloses and claims a breast implant 30 which utilizes a biocompatible radiolucent fill. Radio-j lucency is achieved even at the low intensities of x-rays used for mammography. This radiolucent fill may be com-prised of any biocompatible triglyceride such as peanut ` oil, soybean oil, or any other material having an effec-35 tive atomic number of 6.0 within a range of +0.5, the effective atomic number of body fat. This invention is a ; ..
.,.
.
21~2900 W094/0409~ PCT~US93/078 good and valuable invention which enhances the chances for early detection of cancer in performin~ mammographies on female breasts wh~ch are augmented wlth this breast -`-`! implant. ~
The inventors herein are also aware of pending ~-U.S. Application Serlal No. 07/952,687 filed September , 29, 1992 en~itled Breast Implant W~ th ~ad~olucent Shell, '- the rights to which are owned by the assignee of the present invention and the disclosure of wh~ch is incorpo-10 ra~ed herein by reference, which discloses ancl claims a breast implant having a shell made with radiolucent mate-rials instead of the silicone shell predominantly found in the prior art. The use of radiolucent materials in - the shell el1minates the last vestiges ~f artifacts which 15 might otherwise appear on a radiograph when a mammograph is taken of a breast wlth an implant having radiolucent - f~ll only. This is an important and valuable invention -~
which improves on the '882 patent and demonstrates its - usefulness in those implants for which mammography is 20 customarily used for the early detection of cancer.
In order to solve the various problems in the - prior art re~ating to penile implants, the inventors herein have developed a penile implant using triglyceride as the hydraulic fill, partial radiolucency of the im-25 plant structure to enhance lea~ detection, a radiopaque dye fcr the fill which does not metabolize too rapidly to hinder leak detection, and texturing to eliminate failure of otherwise failure prone implant parts. Significant advantages have been obtained on several grounds. First-30 ly, the radiolucency of the fill and bladder permits the - 1 ' utilization of an x-ray techni~ue having greatly reduced ~ntensities and exposure times to view at least the blad-der portion in the patient's penile shaft for leak detec-- ti~n. Perhaps more important, however, is the dramati-35 cally increased lubrication effect on the hydraulic sys-tem which is experienced with the triglyceride-based .
~: i 2~29 material used~ The typical biocompatible fill material suggested for use in the prior art, which is generally silicone oil or saline, will typ$cally achieve approxi-mately 350,000 cycles before fold flaw failure occurs 5 through rupture or ~hP like of the pen~le implant blad-der. The lnventors herein have perormed testC w$th the hydraulic fill of the pre~ent invention where over 10 million cycles have bee~ completed with no failure ~xpe-r~enced. While 350,000 cycles might ordinarily be con-10 sidered to be adequate for more than the useful life of a penile implant, it must be remembered that prior to fold flaw failure, the abrasive action of the hydraulic f~
- will more likely cause a deterioration ~f the other sys-tem components leading to leakages, or other problems 15 w1thin the system which must be then corrected through surgery. Obviously, surgery is sought to be avoided at all co~ts especially in view of the sens~tive part of the human anatomy involved, both physically as well as psychologically.
In order to enhance leak detection, the implant bladders may be made of radiolucent material, and a radi--- opaque dye added to the triglyceride fill. This enables, for the first time, at least a partial x-ray procedure to be used to detect leaks in the bladder area of the im-25 plant by using x-ray intensities and exposure times much reduced over the intensities and exposure times experi-enced with full body x-rays. ThP harmful effects of x-ray in the testicular area are well known and have been appreciated for many years. This improved implant con-; 30 struction enables at least a portion of the implant to be viewed at much less risk to the patienk. Use of the .~ . j .
radiolucent material for the bladder prevents the bladderitself from obscuring the fill as an appropriate x-ray is taken. Furthermore, as explained above, a phenomenon 35 known as fold flaw failure readily occurs in the bladder of penile implants. This is generally experienced at the .,.-~ :.
.; . .
. ., ~.
" '";1 ",.,., ,,. .... ~, ,,,.,, .. . . , , , . :
W094l04095 2 1 4 2 9 0 0 PCT/US93/078~
point in the bladder where the penis bends to become less obtrusive upon deflation of the implant. This repeated bending and unbending as the implant is inflated and , deflated can cause a fold to occur in the bladder at that 5 point which, after repeated use, can fail by tearing or the like. Thus, th$s important cause of fa$1ure may be ;
i readily d~tected using x-rays which do not expose the entire ~esticular area to th~ x-ray techniques customarl-ly used ln the prlor art.
Still another feature of the present invention is the utillzation of texturing in several parts of the implant in order to increase its biocompat~bility. As explained above, a "capsular contracture" effect can be experlenced at the site of implantation of the res0rvoir.
15 This source of failure can be reduced through the use of tex~uring, as with breast implants~ by texturing the exterior surface of the reservoir. Texturing may also be used in the implant bladders to decrease the tendency for fold flaw failure as the texturing will enhance the inte-20 gration of the bladder surface with the surrounding tis-sue thereby preventing kinking or accute folding upon deflation.
While the principal advantages and features of the present invention have been described above, a more com-25 plete and thorough understanding of the invention may be ~
attained by referring to the drawings and description of ~-- the preferred embodiment which follow.
Brief Description of the Drawin~s The figure is a cross-sectional view of a penile 30 implant with hydraulic system implanted in a patient.
Detailed DescriPtion of the Preferred Embodiment ; As shown in the figure, a penile implant 12 is implanted in the penis 10 of a male patient that includes a bladder 14 having surface texturing on the exterior 35 surface thereof. The bladder 14 may be made from any of the radiolucent materials previously disclosed in the , ~:
.,,,,,,, .:
"
`':
W094/04095 PCT/US93/07&~
~4~9oo related application cross-referenced above. A tubing 16 interconnects the bladder 14 with a pump 18 filled with a hydraulic fill 20 which may be any suitable trlglyceride, such as peanut oil or soybean oil. Any suitable bio-5 compatible material demonstrating the same approximatedegree of lubric~ty and metabolic rate to enhance leak detection may be used. G~nerally, these materials com-prise triglycerides. Another tubing 22 connects the pump 18 wlth a reservoir 24 implanted in the abdomen 28 area 10 of a patient's body, with the exterior surfa~e of reser-voir 24 having texturing 26.
The surface texturing of the bladder and reservoir helps resolve different problems previously experienced in prior art penile implants. With respect to the blad-15 der 14, the surface texturlng helps to prevent the kink-ing in the bladder as tissue grows into the fold general-ly craated as the bladder 14 deflates and the penis 10 fold over or bends downwardly to become less obtrusive. ~;
On the other hand, with respect to the reservoir 24, as 20 mentioned above a scar capsule can form around the reser-voir 24 and contract which would impede its being re-filled wlth hydraulic filler as required to deflate the implant. `
There are various changes and modifications which 25 may be made to the invention as would be apparent to those skilled in the art. However, these changes or modifications are included in the teaching of the dis~
closure, and it is intended that the invention be limited only by the scope of the claims appended hereto.
'.-, .,.................. `
. . :.
". ~
, .... .... . . .... . . .. .. - - -... - . . . . . ... .. - .-. ..
balloon, even when flaccid. Obviously, the cosmetic and aesthetic value of the penile implant would be impaired to the extent that it does not achieve a normal and natu-ral "feel". This "water balloon effect" is more pro-5 nounced in a partially deflated pznis which ~s the pre-dominant condition for the patient's everyday life. This effect is exacerbated by the fact that penile implants are generally not totally deflatable.
The inventors herein are aware of the various 10 texturing and profiling of breast implants which have been developed in the prior art in order to r~nder them more biocompatible and diminish the likelihood of the formation of capsular contracture. Some examples of these are to be found in the following U.S. patents:
15 4,531,244; 4,648,880; 4,899,744; 4,955,907; 4,~55,909;
4,~60,425, 4,963,150; 5,007,929; 5,011,494; 5,022,942;
and 5,092,348, the disclosures of which are incorporated herein by reference. Generally, to the inventors' knowl-edge, these techniques have been used with success in 20 breast implants but their teachings have not been uti-lized with respect to other implants, includ~ng penile implants. Of course, as known in the art, mammographies are performed at significantly reduced x-ray intensities and exposures, levels heretofore not useful with respect 25 to penile implants.
The inventors herein are also aware of U.S. Patent No. 4,995,882, incorporated herein by reference, and rights to which are owned by the assignee of the present invention, which discloses and claims a breast implant 30 which utilizes a biocompatible radiolucent fill. Radio-j lucency is achieved even at the low intensities of x-rays used for mammography. This radiolucent fill may be com-prised of any biocompatible triglyceride such as peanut ` oil, soybean oil, or any other material having an effec-35 tive atomic number of 6.0 within a range of +0.5, the effective atomic number of body fat. This invention is a ; ..
.,.
.
21~2900 W094/0409~ PCT~US93/078 good and valuable invention which enhances the chances for early detection of cancer in performin~ mammographies on female breasts wh~ch are augmented wlth this breast -`-`! implant. ~
The inventors herein are also aware of pending ~-U.S. Application Serlal No. 07/952,687 filed September , 29, 1992 en~itled Breast Implant W~ th ~ad~olucent Shell, '- the rights to which are owned by the assignee of the present invention and the disclosure of wh~ch is incorpo-10 ra~ed herein by reference, which discloses ancl claims a breast implant having a shell made with radiolucent mate-rials instead of the silicone shell predominantly found in the prior art. The use of radiolucent materials in - the shell el1minates the last vestiges ~f artifacts which 15 might otherwise appear on a radiograph when a mammograph is taken of a breast wlth an implant having radiolucent - f~ll only. This is an important and valuable invention -~
which improves on the '882 patent and demonstrates its - usefulness in those implants for which mammography is 20 customarily used for the early detection of cancer.
In order to solve the various problems in the - prior art re~ating to penile implants, the inventors herein have developed a penile implant using triglyceride as the hydraulic fill, partial radiolucency of the im-25 plant structure to enhance lea~ detection, a radiopaque dye fcr the fill which does not metabolize too rapidly to hinder leak detection, and texturing to eliminate failure of otherwise failure prone implant parts. Significant advantages have been obtained on several grounds. First-30 ly, the radiolucency of the fill and bladder permits the - 1 ' utilization of an x-ray techni~ue having greatly reduced ~ntensities and exposure times to view at least the blad-der portion in the patient's penile shaft for leak detec-- ti~n. Perhaps more important, however, is the dramati-35 cally increased lubrication effect on the hydraulic sys-tem which is experienced with the triglyceride-based .
~: i 2~29 material used~ The typical biocompatible fill material suggested for use in the prior art, which is generally silicone oil or saline, will typ$cally achieve approxi-mately 350,000 cycles before fold flaw failure occurs 5 through rupture or ~hP like of the pen~le implant blad-der. The lnventors herein have perormed testC w$th the hydraulic fill of the pre~ent invention where over 10 million cycles have bee~ completed with no failure ~xpe-r~enced. While 350,000 cycles might ordinarily be con-10 sidered to be adequate for more than the useful life of a penile implant, it must be remembered that prior to fold flaw failure, the abrasive action of the hydraulic f~
- will more likely cause a deterioration ~f the other sys-tem components leading to leakages, or other problems 15 w1thin the system which must be then corrected through surgery. Obviously, surgery is sought to be avoided at all co~ts especially in view of the sens~tive part of the human anatomy involved, both physically as well as psychologically.
In order to enhance leak detection, the implant bladders may be made of radiolucent material, and a radi--- opaque dye added to the triglyceride fill. This enables, for the first time, at least a partial x-ray procedure to be used to detect leaks in the bladder area of the im-25 plant by using x-ray intensities and exposure times much reduced over the intensities and exposure times experi-enced with full body x-rays. ThP harmful effects of x-ray in the testicular area are well known and have been appreciated for many years. This improved implant con-; 30 struction enables at least a portion of the implant to be viewed at much less risk to the patienk. Use of the .~ . j .
radiolucent material for the bladder prevents the bladderitself from obscuring the fill as an appropriate x-ray is taken. Furthermore, as explained above, a phenomenon 35 known as fold flaw failure readily occurs in the bladder of penile implants. This is generally experienced at the .,.-~ :.
.; . .
. ., ~.
" '";1 ",.,., ,,. .... ~, ,,,.,, .. . . , , , . :
W094l04095 2 1 4 2 9 0 0 PCT/US93/078~
point in the bladder where the penis bends to become less obtrusive upon deflation of the implant. This repeated bending and unbending as the implant is inflated and , deflated can cause a fold to occur in the bladder at that 5 point which, after repeated use, can fail by tearing or the like. Thus, th$s important cause of fa$1ure may be ;
i readily d~tected using x-rays which do not expose the entire ~esticular area to th~ x-ray techniques customarl-ly used ln the prlor art.
Still another feature of the present invention is the utillzation of texturing in several parts of the implant in order to increase its biocompat~bility. As explained above, a "capsular contracture" effect can be experlenced at the site of implantation of the res0rvoir.
15 This source of failure can be reduced through the use of tex~uring, as with breast implants~ by texturing the exterior surface of the reservoir. Texturing may also be used in the implant bladders to decrease the tendency for fold flaw failure as the texturing will enhance the inte-20 gration of the bladder surface with the surrounding tis-sue thereby preventing kinking or accute folding upon deflation.
While the principal advantages and features of the present invention have been described above, a more com-25 plete and thorough understanding of the invention may be ~
attained by referring to the drawings and description of ~-- the preferred embodiment which follow.
Brief Description of the Drawin~s The figure is a cross-sectional view of a penile 30 implant with hydraulic system implanted in a patient.
Detailed DescriPtion of the Preferred Embodiment ; As shown in the figure, a penile implant 12 is implanted in the penis 10 of a male patient that includes a bladder 14 having surface texturing on the exterior 35 surface thereof. The bladder 14 may be made from any of the radiolucent materials previously disclosed in the , ~:
.,,,,,,, .:
"
`':
W094/04095 PCT/US93/07&~
~4~9oo related application cross-referenced above. A tubing 16 interconnects the bladder 14 with a pump 18 filled with a hydraulic fill 20 which may be any suitable trlglyceride, such as peanut oil or soybean oil. Any suitable bio-5 compatible material demonstrating the same approximatedegree of lubric~ty and metabolic rate to enhance leak detection may be used. G~nerally, these materials com-prise triglycerides. Another tubing 22 connects the pump 18 wlth a reservoir 24 implanted in the abdomen 28 area 10 of a patient's body, with the exterior surfa~e of reser-voir 24 having texturing 26.
The surface texturing of the bladder and reservoir helps resolve different problems previously experienced in prior art penile implants. With respect to the blad-15 der 14, the surface texturlng helps to prevent the kink-ing in the bladder as tissue grows into the fold general-ly craated as the bladder 14 deflates and the penis 10 fold over or bends downwardly to become less obtrusive. ~;
On the other hand, with respect to the reservoir 24, as 20 mentioned above a scar capsule can form around the reser-voir 24 and contract which would impede its being re-filled wlth hydraulic filler as required to deflate the implant. `
There are various changes and modifications which 25 may be made to the invention as would be apparent to those skilled in the art. However, these changes or modifications are included in the teaching of the dis~
closure, and it is intended that the invention be limited only by the scope of the claims appended hereto.
'.-, .,.................. `
. . :.
". ~
, .... .... . . .... . . .. .. - - -... - . . . . . ... .. - .-. ..
Claims (16)
1. In a penile implant, said implant including a pressurized hydraulic system for achieving an erection, the improvement comprising a triglyceride hydraulic fill material for said hydraulic system.
2. The penile implant of Claim 1 wherein said hydraulic fill includes a radiopaque marker.
3. The penile implant of Claim 2 wherein at least some parts of said penile implant are made of materials which are radiolucent at reduced x-ray intensities.
4. The penile implant of Claim 3 wherein said penile implant includes a bladder for inflation to there-by produce an erection, said bladder being constructed of radiolucent material.
5. The penile implant of Claim 2 wherein at least some parts of said penile implant have textured exterior surfaces.
6. The penile implant of Claim 5 wherein said penile implant includes a reservoir for holding a quanti-ty of said hydraulic fill, said reservoir having its exterior surface textured.
7. The penile implant of Claim 5 wherein said penile implant includes a bladder for inflation to there-by produce an erection, said bladder having its exterior surface textured.
8. In a penile implant, said penile implant in-cluding a pressurized hydraulic system for achieving an erection, the improvement comprising a textured exterior surface on at least some parts of said penile implant.
9. The penile implant of Claim 8 wherein said penile implant includes a reservoir for holding a quanti-ty of said hydraulic fill, said reservoir having its exterior surface textured.
10. The penile implant of Claim 9 wherein said penile implant includes a bladder for inflation to there-by produce an erection, said bladder having its exterior surface textured.
11. The penile implant of Claim 10 wherein said hydraulic system includes a triglyceride hydraulic fill material.
12. The penile implant of Claim 11 wherein said hydraulic fill includes a radiopaque marker.
13. A penile implant having a bladder, a reservoir connected to said bladder, hydraulic fluid contained within said reservoir, and means for selectively forcing said hydraulic fluid from said reservoir into said blad-der to thereby produce an erection, said hydraulic fluid being comprised of a triglyceride fluid.
14. The penile implant of Claim 13 wherein said reservoir has an exterior surface and further comprising texturing on said exterior surface.
15. The penile implant of Claim 14 wherein said penile implant includes a bladder for inflation to there-by produce an erection, said bladder having its exterior surface textured.
16. The penile implant of Claim 15 wherein said hydraulic fill includes a radiopaque marker and wherein at least said bladder is made of a material which is radiolucent at reduced x-ray intensities.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93260392A | 1992-08-20 | 1992-08-20 | |
US11030793A | 1993-08-19 | 1993-08-19 | |
US07/932,603 | 1993-08-19 | ||
US08/110,307 | 1993-08-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2142900A1 true CA2142900A1 (en) | 1994-03-03 |
Family
ID=26807903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002142900A Abandoned CA2142900A1 (en) | 1992-08-20 | 1993-08-20 | Penile implant with triglyceride fill |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0656768A4 (en) |
JP (1) | JPH08500504A (en) |
AU (1) | AU5083593A (en) |
BR (1) | BR9306919A (en) |
CA (1) | CA2142900A1 (en) |
WO (1) | WO1994004095A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6251137B1 (en) * | 1994-03-23 | 2001-06-26 | Mcghan Medical Corporation | Synthetic triglyceride filler material for surgically implanted prostheses |
EP0682923A1 (en) * | 1994-05-19 | 1995-11-22 | George Patrick Maxwell | Textured surface penile prosthetic device |
US6290723B1 (en) | 1994-06-14 | 2001-09-18 | Winston A. Andrews | Method of making a synthetic triglyceride filler material |
US7011622B2 (en) | 2000-03-15 | 2006-03-14 | Ams Research Corporation | Parylene coated components for artificial sphincters |
US6558315B1 (en) | 2000-03-15 | 2003-05-06 | Ams Research Corporation | Parylene-coated components for inflatable penile prosthesis |
US7144911B2 (en) | 2002-12-31 | 2006-12-05 | Deciphera Pharmaceuticals Llc | Anti-inflammatory medicaments |
US6902544B2 (en) | 2003-01-22 | 2005-06-07 | Codman & Shurtleff, Inc. | Troubleshooting accelerator system for implantable drug delivery pumps |
US8911350B2 (en) | 2007-10-23 | 2014-12-16 | Ams Research Corporation | Malleable prosthesis with enhanced concealability |
US9408649B2 (en) | 2008-09-11 | 2016-08-09 | Innovasis, Inc. | Radiolucent screw with radiopaque marker |
US9433439B2 (en) | 2009-09-10 | 2016-09-06 | Innovasis, Inc. | Radiolucent stabilizing rod with radiopaque marker |
US8801712B2 (en) | 2010-03-08 | 2014-08-12 | Innovasis, Inc. | Radiolucent bone plate with radiopaque marker |
US9089426B2 (en) | 2012-03-21 | 2015-07-28 | Ams Research Corporation | Automated implantable penile prosthesis pump system |
CN106038031B (en) * | 2016-05-12 | 2018-11-16 | 李明超 | A kind of penis prosthesis controlled using electronic Micropump |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4197846A (en) * | 1974-10-09 | 1980-04-15 | Louis Bucalo | Method for structure for situating in a living body agents for treating the body |
US4550720A (en) * | 1983-11-15 | 1985-11-05 | Medical Engineering Corporation | Capacitance device for medical implant |
US4648880A (en) * | 1984-08-30 | 1987-03-10 | Daniel Brauman | Implantable prosthetic devices |
AU4798785A (en) * | 1984-10-03 | 1986-04-10 | Baylor College Of Medicine | Implant rupture mammography |
US4726360A (en) * | 1986-07-17 | 1988-02-23 | Medical Engineering Corporation | Penile prosthesis |
US4995882A (en) * | 1989-08-28 | 1991-02-26 | Washington University | Radiolucent breast implant |
-
1993
- 1993-08-20 AU AU50835/93A patent/AU5083593A/en not_active Abandoned
- 1993-08-20 JP JP6506551A patent/JPH08500504A/en active Pending
- 1993-08-20 BR BR9306919A patent/BR9306919A/en not_active Application Discontinuation
- 1993-08-20 CA CA002142900A patent/CA2142900A1/en not_active Abandoned
- 1993-08-20 WO PCT/US1993/007844 patent/WO1994004095A1/en not_active Application Discontinuation
- 1993-08-20 EP EP93920240A patent/EP0656768A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO1994004095A1 (en) | 1994-03-03 |
EP0656768A4 (en) | 1996-03-06 |
EP0656768A1 (en) | 1995-06-14 |
BR9306919A (en) | 1999-01-12 |
JPH08500504A (en) | 1996-01-23 |
AU5083593A (en) | 1994-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6533799B1 (en) | Cavity measurement device and method of assembly | |
CA2142900A1 (en) | Penile implant with triglyceride fill | |
ES2216021T3 (en) | NUCLEO OF THE SPINAL PROTEST DISC. | |
US4364379A (en) | Penile erectile system | |
US3954102A (en) | Penile erection system and methods of implanting and using same | |
US3875595A (en) | Intervertebral disc prosthesis and instruments for locating same | |
US4795463A (en) | Labeled breast prosthesis and methods for detecting and predicting rupture of the prosthesis | |
EP0051420B1 (en) | Penile erectile system | |
ES2280201T3 (en) | REPLACEMENT OF PROTESTIC NUCLEUS FOR THE SURGICAL RECONSTRUCTION OF INTERVERTEBRAL DISCS AND TREATMENT METHOD. | |
CN101909534B (en) | Porous containment device for stabilization of vertebral compression fractures | |
EP0072167A1 (en) | Implantable penile erectile system | |
US4187839A (en) | Implantable penile prosthesis | |
US4611584A (en) | Expandable penile implant | |
WO1998055053A1 (en) | Prosthetic spinal disc nucleus | |
JPH05505541A (en) | Biopermeable gel for implant prosthetics | |
KR20060103245A (en) | Artificial lumbar disc and modified posterior lumbar interbody method | |
US5653758A (en) | Method of using a radiolucent organ displacement device for radiation therapy | |
Worton et al. | Late leakage of inflatable silicone breast prostheses | |
PT81245B (en) | Labeled breast prosthesis and methods for decteting and predicting rupture of the prosthesis | |
CA2142996C (en) | Breast implant with radiolucent shell | |
Engel et al. | Experience with the Mentor inflatable penile prosthesis | |
Cohan et al. | Radiology of penile prostheses | |
Wilson | Penile prosthesis implantation: pearls, pitfalls, and perils | |
Kossoff et al. | Inflatable penile implant for impotence: radiologic evaluation | |
Fein | Cylinder problems with AMS 700 inflatable penile prosthesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 20000821 |